DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS

The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions fo...

Full description

Saved in:
Bibliographic Details
Main Authors ATKINSON JONATHAN DAVID MARK, SENGUPTA PRABAL, THENNATI RAJAMANNAR, MEHTA VARUN ANILKUMAR, CHIMANWALA SABBIRHUSEN YUSUFBHAI, CHOKSHI HEMANT ASHVINBHAI, PURI CHETAN SURJITSINGH, DESAI DIPALI MANUBHAI, CHITTURI TRINADHA RAO
Format Patent
LanguageEnglish
Korean
Published 10.02.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals.
Bibliography:Application Number: KR20137021626